India to Papua New Guinea: Pyrimethamine Export Trade Route

The India to Papua New Guinea Pyrimethamine corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $3.9M USD. The route is dominated by IPCA LABORATORIES LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's pyrimethamine manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $486.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with pyrimethamine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 29.3%, placing it at rank #12 among India's top pyrimethamine export destinations globally.

On the import side, key buyers of Indian pyrimethamine in Papua New Guinea include BORNEO PACIFIC PHARMACEUTICALS LTD, MODERN PHARMACEUTICALS LIMITED , KAANA AUSTRALIA PTY LTD and 2 others. BORNEO PACIFIC PHARMACEUTICALS LTD is the single largest importer with 2 shipments valued at $3.7M USD.

India's pyrimethamine exports to Papua New Guinea are driven primarily by a handful of large-scale manufacturers. IPCA LABORATORIES LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Papua New Guinea benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — IPCA LABORATORIES LIMITED, MICRO LABS LIMITED , UNIVERSAL MULTI TRADERS — together account for 100% of total trade value on this route. The average shipment value of $486.7K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as sulfadoxine 500 mg + pyrimethamine 25 mg and harmless medicines laridox (sulfadoxine 500mg & pyrimethamine 25mg tablets) (1x100s) (3360x1x100s pack) unit rate usd, suggesting that buyers in Papua New Guinea tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, BORNEO PACIFIC PHARMACEUTICALS LTD is the largest importer with 2 shipments worth $3.7M USD — representing 96% of all pyrimethamine imports from India on this route.